论文信息 - Lung adenocarcinoma with BRAF G469L mutation refractory to vemurafenib. - 字舞流文

Lung adenocarcinoma with BRAF G469L mutation refractory to vemurafenib.

S. Peters | V. Zoete | O. Michielin | J. Diebold | K. Strobel | O. Gautschi | A. Hirschmann | Franziska Aebersold-Keller | B. Schwizer